Compare ULH & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULH | LAB |
|---|---|---|
| Founded | 1932 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.1M | 354.1M |
| IPO Year | 2004 | 2008 |
| Metric | ULH | LAB |
|---|---|---|
| Price | $20.81 | $0.89 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $20.00 | $1.35 |
| AVG Volume (30 Days) | 50.7K | ★ 2.0M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,461,708,000.00 | $101,937,000.00 |
| Revenue This Year | $4.02 | N/A |
| Revenue Next Year | $3.02 | $2.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.78 | $0.87 |
| 52 Week High | $30.76 | $1.72 |
| Indicator | ULH | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 54.65 | 35.40 |
| Support Level | $14.23 | N/A |
| Resistance Level | $20.78 | $1.39 |
| Average True Range (ATR) | 1.56 | 0.04 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 39.00 | 18.13 |
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.